These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 17709158

  • 1. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
    Huang J, Cao Y, Du J, Bu X, Ma R, Wu C.
    Vaccine; 2007 Sep 28; 25(39-40):6981-91. PubMed ID: 17709158
    [Abstract] [Full Text] [Related]

  • 2. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
    Zhi Y, Kobinger GP, Jordan H, Suchma K, Weiss SR, Shen H, Schumer G, Gao G, Boyer JL, Crystal RG, Wilson JM.
    Virology; 2005 Apr 25; 335(1):34-45. PubMed ID: 15823604
    [Abstract] [Full Text] [Related]

  • 3. CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein.
    Zhao K, Yang B, Xu Y, Wu C.
    Vaccine; 2010 Sep 24; 28(41):6666-74. PubMed ID: 20709007
    [Abstract] [Full Text] [Related]

  • 4. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses.
    Huang J, Ma R, Wu CY.
    Vaccine; 2006 Jun 05; 24(23):4905-13. PubMed ID: 16621188
    [Abstract] [Full Text] [Related]

  • 5. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
    Hu H, Lu X, Tao L, Bai B, Zhang Z, Chen Y, Zheng F, Chen J, Chen Z, Wang H.
    Clin Vaccine Immunol; 2007 Jul 05; 14(7):894-901. PubMed ID: 17494640
    [Abstract] [Full Text] [Related]

  • 6. Immunization of mice with a DNA vaccine based on severe acute respiratory syndrome coronavirus spike protein fragment 1.
    Zhao B, Jin NY, Wang RL, Zhang LS, Zhang YJ.
    Viral Immunol; 2006 Jul 05; 19(3):518-24. PubMed ID: 16987069
    [Abstract] [Full Text] [Related]

  • 7. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
    Channappanavar R, Fett C, Zhao J, Meyerholz DK, Perlman S.
    J Virol; 2014 Oct 05; 88(19):11034-44. PubMed ID: 25056892
    [Abstract] [Full Text] [Related]

  • 8. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.
    Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, Zheng BJ.
    Vaccine; 2008 Mar 20; 26(13):1644-51. PubMed ID: 18289745
    [Abstract] [Full Text] [Related]

  • 9. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins.
    Tsao YP, Lin JY, Jan JT, Leng CH, Chu CC, Yang YC, Chen SL.
    Biochem Biophys Res Commun; 2006 May 26; 344(1):63-71. PubMed ID: 16630549
    [Abstract] [Full Text] [Related]

  • 10. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.
    Martin JE, Louder MK, Holman LA, Gordon IJ, Enama ME, Larkin BD, Andrews CA, Vogel L, Koup RA, Roederer M, Bailer RT, Gomez PL, Nason M, Mascola JR, Nabel GJ, Graham BS, VRC 301 Study Team.
    Vaccine; 2008 Nov 25; 26(50):6338-43. PubMed ID: 18824060
    [Abstract] [Full Text] [Related]

  • 11. A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.
    Wang X, Xu W, Tong D, Ni J, Gao H, Wang Y, Chu Y, Li P, Yang X, Xiong S.
    Immunol Lett; 2008 Aug 15; 119(1-2):71-7. PubMed ID: 18533276
    [Abstract] [Full Text] [Related]

  • 12. Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif.
    Poh WP, Narasaraju T, Pereira NA, Zhong F, Phoon MC, Macary PA, Wong SH, Lu J, Koh DR, Chow VT.
    J Med Virol; 2009 Jul 15; 81(7):1131-9. PubMed ID: 19475608
    [Abstract] [Full Text] [Related]

  • 13. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H, Wang G, Li J, Nie Y, Shi X, Lian G, Wang W, Yin X, Zhao Y, Qu X, Ding M, Deng H.
    J Virol; 2004 Jul 15; 78(13):6938-45. PubMed ID: 15194770
    [Abstract] [Full Text] [Related]

  • 14. Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates.
    Liu SJ, Leng CH, Lien SP, Chi HY, Huang CY, Lin CL, Lian WC, Chen CJ, Hsieh SL, Chong P.
    Vaccine; 2006 Apr 12; 24(16):3100-8. PubMed ID: 16494977
    [Abstract] [Full Text] [Related]

  • 15. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
    He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S.
    Virology; 2005 Mar 30; 334(1):74-82. PubMed ID: 15749124
    [Abstract] [Full Text] [Related]

  • 16. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.
    Woo PC, Lau SK, Tsoi HW, Chen ZW, Wong BH, Zhang L, Chan JK, Wong LP, He W, Ma C, Chan KH, Ho DD, Yuen KY.
    Vaccine; 2005 Oct 10; 23(42):4959-68. PubMed ID: 15993989
    [Abstract] [Full Text] [Related]

  • 17. Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction.
    Huang J, Cao Y, Bu X, Wu C.
    BMC Immunol; 2012 Sep 10; 13():50. PubMed ID: 22963340
    [Abstract] [Full Text] [Related]

  • 18. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.
    He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, Jiang S.
    J Immunol; 2004 Sep 15; 173(6):4050-7. PubMed ID: 15356154
    [Abstract] [Full Text] [Related]

  • 19. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B, Casares N, Egea J, Ruiz M, Llopiz D, Maestro S, Olagüe C, González-Aseguinolaza G, Smerdou C, López-Díaz de Cerio A, Inogés S, Prósper F, Yuste JR, Carmona-Torre F, Reina G, Lasarte JJ, Sarobe P.
    Emerg Microbes Infect; 2021 Dec 15; 10(1):1931-1946. PubMed ID: 34538222
    [Abstract] [Full Text] [Related]

  • 20. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection.
    Du L, Zhao G, Lin Y, Sui H, Chan C, Ma S, He Y, Jiang S, Wu C, Yuen KY, Jin DY, Zhou Y, Zheng BJ.
    J Immunol; 2008 Jan 15; 180(2):948-56. PubMed ID: 18178835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.